Oncotarget

Vol 9, No 78

October 5, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 78 of Oncotarget features Figure 4, "Effect of FKBP51 KO on glucocorticoid response and Akt/mTOR in HaCaT human keratinocytes," by Baida, et al.

Table of Contents

Editorial

Influence of Scribble polarity complex on hematopoiesis and leukemia – a matter of where, when and how

Influence of Scribble polarity complex on hematopoiesis and leukemia – a matter of where, when and how

https://doi.org/10.18632/oncotarget.26132

Florian H. Heidel,  and Sarah Ellis
34642-34643
PDF  |  Order a Reprint

Research Papers

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

https://doi.org/10.18632/oncotarget.26141

Qingyan Cui, Frank Vari, Alexandre S. Cristino, Carlos Salomon, Gregory E. Rice, Muhammed B. Sabdia, Dominic Guanzon, Carlos Palma, Marina Mathew, Dipti Talaulikar, Sanjiv Jain, Erica Han, Mark S. Hertzberg, Clare Gould, Pauline Crooks, Gayathri Thillaiyampalam, Colm Keane,  and Maher K. Gandhi
34644-34657
Abstract  |  PDF  |  HTML  |  Order a Reprint

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells

The anti-cancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells

https://doi.org/10.18632/oncotarget.26157

Shirin R. Modarai, Anindita Gupta, Lynn M. Opdenaker, Ryan Kowash, Gabriel Masters, Vignesh Viswanathan, Tao Zhang, Jeremy Z. Fields,  and Bruce M. Boman
34658-34669
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells

The transgenic expression of the β-subunit of human chorionic gonadotropin influences the growth of implanted tumor cells

https://doi.org/10.18632/oncotarget.26158

Poonam Singh, Moumita Sarkar, Usha Agrawal, Ilpo Huhtaniemi,  and Rahul Pal
34670-34680
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts

ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts

https://doi.org/10.18632/oncotarget.26159

Mysoon M. Al-Ansari,  and Abdelilah Aboussekhra
34681-34690
Abstract  |  PDF  |  HTML  |  Order a Reprint

Obesity and Alzheimer’s disease, does the obesity paradox really exist? A magnetic resonance imaging study

Obesity and Alzheimer’s disease, does the obesity paradox really exist? A magnetic resonance imaging study

https://doi.org/10.18632/oncotarget.26162

Jordi Pegueroles, Amanda Jiménez, Eduard Vilaplana, Victor Montal, María Carmona-Iragui, Adriana Pané, Daniel Alcolea, Laura Videla, Anna Casajoana, Jordi Clarimón, Emilio Ortega, Josep Vidal, Rafael Blesa, Alberto Lleó,  and Juan Fortea for the Alzheimer’s Disease Neuroimaging Initiative
34691-34698
Abstract  |  PDF  |  HTML  |  Order a Reprint

β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage

β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage

https://doi.org/10.18632/oncotarget.26165

Antonino Tuttolomondo, Rosario Maugeri, Elisabetta Orlando, Giulio Giannone, Francesco Ciccia, Aroldo Rizzo, Domenico Di Raimondo, Francesca Graziano, Rosaria Pecoraro, Carlo Maida, Irene Simonetta, Anna Cirrincione, Francesca Portelli, Francesca Corpora, Domenico Gerardo Iacopino,  and Antonio Pinto
34699-34707
Abstract  |  PDF  |  HTML  |  Order a Reprint

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma

DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma

https://doi.org/10.18632/oncotarget.26168

Prashant Bommi, Sriram Ravindran, Pradip Raychaudhuri,  and Srilata Bagchi
34708-34718
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells

https://doi.org/10.18632/oncotarget.26176

Norihiko Sasaki, Masashi Toyoda, Hisashi Yoshimura, Yoko Matsuda, Tomio Arai, Kaiyo Takubo, Junko Aida,  and Toshiyuki Ishiwata
34719-34734
Abstract  |  PDF  |  HTML  |  Order a Reprint

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines

https://doi.org/10.18632/oncotarget.26187

Liu Lu, Chung Hoow Kok, Verity Ann Saunders, Jueqiong Wang, Jennifer Anne McLean, Timothy Peter Hughes,  and Deborah Lee White
34735-34747
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats

Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats

https://doi.org/10.18632/oncotarget.26190

Kiyoshi Terawaki, Yohei Kashiwase, Miaki Uzu, Miki Nonaka, Yumi Sawada, Kanako Miyano, Yoshikazu Higami, Kazuyoshi Yanagihara, Masahiro Yamamoto,  and Yasuhito Uezono
34748-34764
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?

Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previously-negative patients?

https://doi.org/10.18632/oncotarget.26192

Akito Hata, Nobuyuki Katakami, Reiko Kaji, Toshihide Yokoyama, Toshihiko Kaneda, Motohiro Tamiya, Takako Inoue, Hiromi Kimura, Yukihiro Yano, Daisuke Tamura, Satoshi Morita,  and Shunichi Negoro
34765-34771
Abstract  |  PDF  |  HTML  |  Order a Reprint

Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy

Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy

https://doi.org/10.18632/oncotarget.26194

Gleb Baida, Pankaj Bhalla, Alexander Yemelyanov, Lance A. Stechschulte, Weinian Shou, Ben Readhead, Joel T. Dudley, Edwin R. Sánchez,  and Irina Budunova
34772-34783
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical impact of serum soluble SLAMF7 in multiple myeloma

Clinical impact of serum soluble SLAMF7 in multiple myeloma

https://doi.org/10.18632/oncotarget.26196

Mariko Ishibashi, Saori Soeda, Makoto Sasaki, Hiroshi Handa, Yoichi Imai, Norina Tanaka, Sakae Tanosaki, Shigeki Ito, Takeshi Odajima, Hiroki Sugimori, Toshio Asayama, Mika Sunakawa, Yuta Kaito, Ryosuke Kinoshita, Yasuko Kuribayashi, Asaka Onodera, Keiichi Moriya, Junji Tanaka, Yutaka Tsukune, Norio Komatsu, Koiti Inokuchi,  and Hideto Tamura
34784-34793
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients

Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients

https://doi.org/10.18632/oncotarget.26198

Alexandra Samsen, Silvia von der Heyde, Carsten Bokemeyer, Kerstin A. David, Bernd Flath, Max Graap, Bianca Grebenstein, Ludger Heflik, Wiebke Hollburg, Peter Layer, Eike von Leitner, Friedrich Overkamp, Wolfgang Saeger, Sandra Schneider, Cay-Uwe von Seydewitz, Axel Stang, Alexander Stein, Carsten Zornig,  and Hartmut Juhl
34794-34809
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

https://doi.org/10.18632/oncotarget.26199

Janneke S. Hoogstad-van Evert, Ralph J. Maas, Jolien van der Meer, Jeannette Cany, Sophieke van der Steen, Joop H. Jansen, Jeffrey S. Miller, Ruud Bekkers, Willemijn Hobo, Leon Massuger,  and Harry Dolstra
34810-34820
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ

PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ

https://doi.org/10.18632/oncotarget.26201

Adam Harvey, Nicholas Mielke, Julia W. Grimstead, Rhiannon E. Jones, Thanh Nguyen, Matthew Mueller, Duncan M. Baird,  and Eric A. Hendrickson
34821-34837
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway

Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NF-κB pathway

https://doi.org/10.18632/oncotarget.26208

Fatemeh Momen-Heravi,  and Shashi Bala
34838-34854
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Errata

Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme

Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme

https://doi.org/10.18632/oncotarget.26219

Amparo Wolf, Sameer Agnihotri,  and Abhijit Guha
34855-34855
Erratum  |  PDF

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells

Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells

https://doi.org/10.18632/oncotarget.26220

Joshua C. Curtin,  and Matthew V. Lorenzi
34856-34856
Erratum  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC